UBS’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$174K Sell
9,950
-4,662
-32% -$81.5K ﹤0.01% 3822
2014
Q2
$292K Sell
14,612
-21,771
-60% -$435K ﹤0.01% 3507
2014
Q1
$694K Buy
36,383
+27,875
+328% +$532K ﹤0.01% 2931
2013
Q4
$142K Sell
8,508
-655
-7% -$10.9K ﹤0.01% 3842
2013
Q3
$139K Buy
+9,163
New +$139K ﹤0.01% 3774